Dr. Hassman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 White Horse Pike
Clementon, NJ 08021Phone+1 856-566-9000Fax+1 856-566-4101
Education & Training
Philadelphia College of Osteopathic MedicineClass of 1983
Certifications & Licensure
FL State License 2010 - 2026
NJ State License 1984 - 2025
CA State License 1984 - 2024
PA State License 1984 - 2024
Clinical Trials
- Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose Start of enrollment: 2009 Jan 01
- SUBLOCADE Rapid Initiation Study Start of enrollment: 2019 Aug 29
Publications & Presentations
PubMed
- 3 citationsA Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.Milton H Werner, C Warren Olanow, Andrew McGarry, Christopher Meyer, Sydney Kruger
Journal of Parkinson's Disease. 2024-01-01 - 6 citationsOpen-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection.Howard Hassman, Stephanie Strafford, Sunita N Shinde, Amy Heath, Brent Boyett
The American Journal of Drug and Alcohol Abuse. 2023-01-02 - 7 citationsThe Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence StudyDavid P. Walling, Howard A Hassman, Lourdes Anta, Lourdes Ochoa, Ignacio Ayani
Drug Design, Development and Therapy. 2021-10-15
Press Mentions
Apex Innovation Sciences Forms from Three Way MergerOctober 2nd, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
